Augmentation Strategies

CNS Spectrums

Volumn 14, Issue S4, 2009, Pages 7-10

  Thase, Michael E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; LITHIUM DERIVATIVE; THYROID HORMONE;

ARTICLE; DRUG COMBINATION; HUMAN; MAJOR DEPRESSION; TREATMENT FAILURE;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DRUG THERAPY, COMBINATION; HUMANS; LITHIUM COMPOUNDS; THYROID HORMONES; TREATMENT FAILURE;

EID: 65649107232     PISSN: 10928529     EISSN: 21656509     Source Type: Journal    
DOI: 10.1017/S1092852900003515     Document Type: Article

References (20)

1. Thase, ME, Denko, T. Pharmacotherapy of mood disorders. Annu Rev Clin Psychol. 2008; 4: 53–91.
2. Thase, ME, Schutte, AJ, van der flier, S, Heukels, A. Remission with mirtazapine versus SSRIs: a meta-analysis on data of more than 2500 depressed patients treated in randomised controlled trials. J Affect Disord. 2004; 78 (suppl 1):S136.
3. Rush, AJ, Trivedi, MH, Wisniewski, SR, et al. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med. 2006; 354(12):1231–1242.
4. Ruhe, HG, Huyser, J, Swinkels, JA, Schene, AH. Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review. J Clin Psychiatry. 2006; 67(12):1836–1855.
5. Thase, ME. Therapeutic alternatives for difficult-to-treat depression: a narrative review of the state of the evidence. CNS Spectr. 2004; 9(11):808–816, 818–821.
6. Fava, M, Rush, AJ, Alpert, JE, et al. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry. 2008; 165(3):342–351.
7. Poirier, MF, Boyer, P. Venlafaxine and paroxetine in treatment-resistant depression. Double-blind, randomised comparison. Br J Psychiatry. 1999; 175: 12–16.
8. Sussman, N. Anxiolytic antidepressant augmentation. J Clin Psychiatry. 1998; 59(suppl 5):42–48; discussion 49–50.
9. Fava, M, Thase, ME, DeBattista, C, Doghramji, K, Arora, S, Hughes, RJ. Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness. Ann Clin Psychiatry. 2007; 19(3):153–159.
10. Thase, ME, Fava, M, DeBattista, C, Arora, S, Hughes, RJ. Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12-week, open-label, extension study. CNS Spectr. 2006; 11(2):93–102.
11. Carvalho, AF, Cavalcante, JL, Castelo, MS, Lima, MC. Augmentation strategies for treatment-resistant depression: a literature review. J Clin Pharm Ther. 2007; 32(5):415–428.
12. DeBattista, C. Augmentation and combination strategies for depression. J Psychopharmacol. 2006; 20(suppl 3):11–18.
13. Aronson, R, Offman, HJ, Joffe, RT, Naylor, CD. Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis. Arch Gen Psychiatry. 1996; 53(9):842–848.
14. Crossley, NA, Bauer, M. Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials. J Clin Psychiatry. 2007; 68(6):935–940.
15. Nierenberg, AA, Fava, M, Trivedi, MH, et al. A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report. Am J Psychiatry. 2006; 163(9):1519–1530; quiz 1665.
16. Bauer, M, Dopfmer, S. Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies. J Clin Psychopharmacol. 1999; 19(5):427–434.
17. Thase, ME. Depression and sleep: pathophysiology and treatment. Dialogues Clin Neurosci. 2006; 8(2):217–226.
18. Trivedi, MH, Fava, M, Wisniewski, SR, et al. Medication augmentation after the failure of SSRIs for depression. N Engl J Med. 2006; 354(12):1243–1252.
19. Fava, M, McCall, WV, Krystal, A, et al. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry. 2006; 59(11):1052–1060.
20. Smith, WT, Londborg, PD, Glaudin, V, Painter, JR. Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: a double-blind study. Am J Psychiatry. 1998; 155(10):1339–1345.